Cyril Poupet - Search Results

Year	Number of Results
2019	2
2020	3
2021	1
2022	1
2024	1

1

Caenorhabditis elegans, a Host to Investigate the Probiotic Properties of Beneficial Microorganisms.

Poupet C, Chassard C, Nivoliez A, Bornes S. Poupet C, et al. Front Nutr. 2020 Aug 21;7:135. doi: 10.3389/fnut.2020.00135. eCollection 2020. Front Nutr. 2020. PMID: 33425969 Free PMC article. Review.

2

A Mechanistic Study of the Antiaging Effect of Raw-Milk Cheese Extracts.

Cardin G, Poupet C, Bonnet M, Veisseire P, Ripoche I, Chalard P, Chauder A, Saunier E, Priam J, Bornes S, Rios L. Cardin G, et al. Among authors: poupet c. Nutrients. 2021 Mar 10;13(3):897. doi: 10.3390/nu13030897. Nutrients. 2021. PMID: 33802038 Free PMC article.

3

In vivo investigation of Lcr35^® anti-candidiasis properties in Caenorhabditis elegans reveals the involvement of highly conserved immune pathways.

Poupet C, Rifa É, Theil S, Bonnet M, Veisseire P, Cardin G, Guéret É, Rialle S, Chassard C, Nivoliez A, Bornes S. Poupet C, et al. Front Microbiol. 2022 Dec 23;13:1062113. doi: 10.3389/fmicb.2022.1062113. eCollection 2022. Front Microbiol. 2022. PMID: 36620055 Free PMC article.

4

Development of an innovative methodology combining chemical fractionation and in vivo analysis to investigate the biological properties of cheese.

Cardin G, Ripoche I, Poupet C, Bonnet M, Veisseire P, Chalard P, Chauder A, Saunier E, Priam J, Bornes S, Rios L. Cardin G, et al. Among authors: poupet c. PLoS One. 2020 Nov 19;15(11):e0242370. doi: 10.1371/journal.pone.0242370. eCollection 2020. PLoS One. 2020. PMID: 33211771 Free PMC article.

5

Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidate.

Guerriaud M, Poupet C, Lakhrif Z, Kohli E, Moiré N. Guerriaud M, et al. Among authors: poupet c. Gene Ther. 2024 Mar 1. doi: 10.1038/s41434-024-00445-1. Online ahead of print. Gene Ther. 2024. PMID: 38429432

6

Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.

Poupet C, Saraoui T, Veisseire P, Bonnet M, Dausset C, Gachinat M, Camarès O, Chassard C, Nivoliez A, Bornes S. Poupet C, et al. PLoS One. 2019 Nov 6;14(11):e0216184. doi: 10.1371/journal.pone.0216184. eCollection 2019. PLoS One. 2019. PMID: 31693670 Free PMC article.

7

Investigation into In Vitro and In Vivo Caenorhabditis elegans Models to Select Cheese Yeasts as Probiotic Candidates for their Preventive Effects against Salmonella Typhimurium.

Veisseire P, Bonnet M, Saraoui T, Poupet C, Camarès O, Gachinat M, Callon C, Febvre G, Chassard C, Bornes S. Veisseire P, et al. Among authors: poupet c. Microorganisms. 2020 Jun 18;8(6):922. doi: 10.3390/microorganisms8060922. Microorganisms. 2020. PMID: 32570901 Free PMC article.

8

Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism Lactobacillus rhamnosus Lcr35^® in the Invertebrate Model Caenorhabditis elegans: First Mechanistic Insights.

Poupet C, Veisseire P, Bonnet M, Camarès O, Gachinat M, Dausset C, Chassard C, Nivoliez A, Bornes S. Poupet C, et al. Microorganisms. 2019 Dec 23;8(1):34. doi: 10.3390/microorganisms8010034. Microorganisms. 2019. PMID: 31878039 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year